DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

8.16 0.15 (1.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $8.16 1.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.04
Previous Close $8.01
Daily Range $7.85 - $8.18
52-Week Range $5.60 - $12.46
Market Cap $845.5M
P/E Ratio -6.86
Dividend (Yield) $0.00 (0.0%)
Volume 263,688
Average Daily Volume 489,543
Current FY EPS -$1.30

Sector

Healthcare

Industry

Drug Makers

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexpharma.com/

News & Commentary Rss Feed

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Lexicon Pharmaceuticals (LXRX) Weak On High Volume Today

Lexicon Pharmaceuticals (LXRX) Shares March Higher, Can It Continue? - Tale of the Tape

Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?

Today's Weak On High Volume Stock: Lexicon Pharmaceuticals (LXRX)

Lexicon Undervalued As It Approaches A Major Event

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earnings Call Transcript

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syn

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

Health Care Sector Update for 04/15/2015: LXRX,BMY,CLSN,AKBA

Health Care Sector Update for 04/15/2015: LXRX, GLMD, NAVB

Jefferies: 10 Buyout Targets To Own During The M&A Boom

See More LXRX News...

LXRX's Top Competitors

LXRX $8.16 (1.87%)
Current stock: LXRX
BIIB $404.28 (-0.28%)
Current stock: BIIB
AMGN $153.26 (-1.12%)
Current stock: AMGN
CELG $119.52 (1.10%)
Current stock: CELG